Democratizing Medicine and Research

Democratizing Medicine and Research

How is cannabis a disrupter to the pharmaceutical industry and also a democratizing factor in getting medicine into the hands of patients?

This panel discusses the current state of medicine, healthcare, and scientific research, and what we can do to “democratize medicine.” This panel also discusses opportunities cannabis companies have to establish their own IP, while mega-corporations and big-pharma are held at bay by current federal laws.

Dr. Michael Masterman-Smith (PhD) / Sheila Gibson (Esq) / John Claybron Poss / Dr. Stuart Silverman

John Clayborn Poss
John Poss serves as The CEO & Chairman of GB Sciences, Inc., a cutting edge cannabis cultivation and biopharmaceutical research company.

Dr. Michael Masterman-Smith
Dr. Michael Masterman-Smith is an entrepreneurial scientist, cancer biologist, pharmacologist, and healthcare expert who holds the distinction of being one of the co-discoverers of cancer stem cells.

Dr. Michael Masterman-Smith is a leading entrepreneurial scientist, cancer biologist, pharmacologist and healthcare expert. He found his initial calling to medical research while working with pediatric brain tumor patients. Seeing kids in pain and suffering led him to the lab and his fortuitous co-discovery of cancer stem cells in 2003.

As one of the first STEM trained scientists in the historic California NanoSystems Institute (CNSI), he developed advanced single cell analysis technologies for precision oncology and next generation nanoelectronics for ‘smart’ lenses, consumer electronics, wearable medical devices, digital health, and applications in aerospace and aviation.

Though initially met with skepticism from the cancer community in identifying the ‘cells-of-origin’ for cancer, this research ultimately was deemed a high impact discovery by the National Cancer Institute in 2013. The discovery has led to a transformational shift in how to treat cancer and helped steer more than $60 billion in global investment for better treatments for some of the most malignant and deadly cancers.

He had the great fortune of being selected to be an inaugural STEM scientist in the historic California NanoSystems Institute (CNSI) technology incubator where he specialized in ‘blue sky’ projects, inventing and moving innovative medical technologies from the lab bench to the hospital bedside. His current efforts include multidisciplinary approaches to understanding and treating pain, combating the opioid epidemic, improving clinical trials and reducing their cost, enabling precision cancer diagnostics and engineering invisible, ultralight nanoelectronics for next generation ‘smart’ contact lenses and heads up displays for pilots.

Michael was a candidate for the U.S. House of Representatives in 2018, sits on various nonprofit and company boards, founded and runs several start-up companies and consults governments, institutions and companies on R & D, medical and healthcare initiatives.

Dr. Stuart Silverman
A faculty member of the UCLA Cannabis Research Initiative, Dr. Silverman is also a Professor at both Cedars Sinai Medical Center and the David Geffen School of Medicine at UCLA. He has published more than 200 peer reviewed papers.

Stuart Silverman M.D. is a rheumatology physician, cannabis clinician and researcher in private practice who is a clinical Professor at both Cedars Sinai Medical Center and the David Geffen School of Medicine at UCLA. He is a faculty member of the UCLA Cannabis Research Initiative.

He has spoken on the topic of cannabis at venues ranging nationally from Princeton University to locally at TEC-Leimert and giving Grand Rounds on cannabis at both Cedars Sinai and UCLA. He is the author of over 200 peer reviewed original papers. He has served as director of the Cedars Sinai outpatient Fibromyalgia Rehab program and Acting Chief of Rheumatology at West Los Angeles VA Medical Center.

He has served on the Scientific Advisory Board of Kalytera Pharma, which is developing CBD and cannabinoids for treatment of disease, and has worked with Niamedic, an Israeli healthcare and research company specialized in integrating medical cannabis treatments.

He is part of a diversity initiative at UCRI and has started qualitative research on the cannabis journey in different racial/ethnic groups as well as working with UCRI on educational initiatives.

Sheila Gibson, Esq.
Sheila Gibson brings deep IP experience to helping independent cannabis operators hold their ground as corporate interests attempt to takeover.

This video is from the Microscopes & Machines conference in LA.

https://microscopesandmachines.com

THANKS TO OUR SUPPORTERS
Boveda – https://bovedainc.com/store/herbal/
Global Garden – https://www.globalgarden.co/
Simplify – https://www.simplifya.com/
Linx Kiosk – http://www.linxkiosk.com/
MMLG – https://mmlg.com/
Clark Neubert – http://greenfrontier.com/
CannaRegs – https://www.cannaregs.com/
Green Bits – https://www.greenbits.com/